-
Loading metrics
Sequencing Therapy for Optimal Response in Mirikizumab (STORM)-study: A tertiary referral center study on patients with therapy-refractory ulcerative colitis
- Alica Kubesch,
- Raul Lande,
- Anna Leutgöb,
- Karima Farrag,
- Iulia Dahmer,
- Katharina Stratmann-Vollrath,
- Antje Dienethal,
- Florian Alexander Michael,
- Kathrin Sprinzl,
- Stefan Zeuzem
x
- Published: October 24, 2025
- https://doi.org/10.1371/journal.pone.0334897